Article

BVI purchases ophthalmic assets from Odyssey

Beaver-Visitec International Inc. (BVI) has purchased the ophthalmic assets from Odyssey Medical Inc., which specializes in dry eye solutions.

 

Waltham, MA-Beaver-Visitec International Inc. (BVI) has purchased the ophthalmic assets from Odyssey Medical Inc., which specializes in dry eye solutions. BVI is a portfolio company of RoundTable Healthcare Partners, an operating-oriented private equity firm focused on the healthcare industry.

“We are excited to bring Odyssey to our customers as a part of the Beaver-Visitec family,” said Tom Kapfer, chief executive officer of BVI. “We are committed to providing high-quality single-use products with the performance and precision clinicians expect. Odyssey is a perfect fit with our goal.”

"BVI and Odyssey both believe in offering the best products to our customers,” added Barbara Tatge, a former owner of Odyssey who will be joining BVI. “This shared value is what attracted us to BVI.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.